Next report date
Report period
Q1 2024
EPS estimate
−0.86USD
Revenue estimate
—
−60.39 MUSD
20.70 M
Om Acrivon Therapeutics, Inc.
Sektor
Bransch
VD
Peter Blume-Jensen
Webbplats
Huvudkvarter
Watertown
Employees (FY)
58
Grundat
2018
FIGI
BBG011RWR2Q4
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
